Table 1.
Overall (n, %) | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
---|---|---|---|---|---|---|---|
Total enrolled patients | 4028 | 416 | 665 | 686 | 917 | 732 | 612 |
Positive respiratory infections | 1635 (40·6) | 75 (18·0) | 179 (6·9) | 335 (48·8) | 474 (51·7) | 345 (47·1) | 227 (37·1) |
ADV infection | 402 (10·0) | 5 (1·2) | 54 (8·1) | 53 (7·7) | 102 (11·1) | 157 (21·4) | 31 (5·1) |
hBoV infection | 106 (2·6) | 1 (0·2) | 5 (0·8) | 34 (5·0) | 28 (3·1) | 26 (3·6) | 12 (2·0) |
PIV infection | 194 (4·8) | 1 (0·2) | 1 (0·2) | 28 (4·1) | 69 (7·5) | 50 (6·8) | 45 (7·4) |
RSV infection | 183 (4·5) | 10 (2·4) | 16 (2·4) | 57 (8·3) | 65 (7·1) | 21 (2·9) | 14 (2·3) |
RSV subgroup (A/B) | |||||||
RSV-A | 141 (3·5) | 9 (2·2) | 1 (0·2) | 52 (7·6) | 60 (6·5) | 9 (1·2) | 10 (1·6) |
RSV-B | 33 (0·8) | 0 | 8 (1·2) | 5 (0·7) | 4 (0·4) | 12 (1·6) | 4 (0·7) |
RSV-A and B | 1 (0·0) | 0 | 0 | 0 | 1 (0·1) | 0 | 0 |
hCoV infection | 112 (2·8) | 12 (2·9) | 13 (2·0) | 19 (2·8) | 25 (2·7) | 21 (2·9) | 22 (3·6) |
hMPV infection | 40 (1·0) | – | 6 (0·9) | 7 (1·0) | 3 (0·3) | 7 (1·0) | 16 (2·6) |
hRV infection | 573 (14·2) | 45 (10·8) | 60 (9·0) | 137 (20·0) | 181 (19·7) | 63 (8·6) | 87 (14·2) |
IFV infection | 920 (22·8) | 91 (21·9) | 217 (32·6) | 62 (9·0) | 333 (36·3) | 86 (11·7) | 131 (21·4) |
Bold values are target virus value (RSV) in our study.